Explore

Companies

Drugs

/

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Other/Recovery

Recovery

32

Pipeline Programs↗

38

Active Trials↗

20

Companies Involved↗

Recovery is a moderately active landscape with 32 programs across 20 companies. 4 programs are in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

59/100

Pipeline Velocity

48/100

Mech. Concentration

25/100

Completion Rate

85/100

Attrition Rate

10/100

Pipeline

Programs by Phase

Preclinical21

Blood Collection

Assistance Publique - Hôpitaux de Paris

L-Tyrosine

Direction Centrale du Service de Santé des Armées

Dual NRT

Massachusetts General Hospital

Aloe Vera Soup

University of Thessaly

Natural Aloe Vera

University of Thessaly

Phase 15

Propofol and Ketamine

Zagazig University

Tramadol Plus Paracetamol

Zagazig University

Fentanyl

Cephalon

Propofol

Fresenius Kabi USA, LLC

Methadone

Hikma Pharmaceuticals LLC

Phase 22

N-Acetyl-L-Cysteine

Peking University People's Hospital

BXCL501

BioXcel Therapeutics Inc

Phase 34

Аrgon-Oxygen Breathing Mixture

Negovsky Reanimatology Research Institute

Cannabidiol

Jazz Pharmaceuticals

Prevention of Venous Thromboembolism

Prof. Stavros Konstantinides, MD

Dexmedetomidine-Esketamine

Peking University First Hospital

Approved

No programs

Analysis

Trial Status

182

clinical trials

Completed105 · 58%

Unknown status21 · 12%

Not yet recruiting17 · 9%

Recruiting15 · 8%

Terminated10 · 5%

Withdrawn8 · 4%

Other6 · 3%

Clinical Trials

Trial Activity

182 trials

Effect of Blood Flow Restriction on Recovery After Maximal Resistance Exercise: a Controlled Clinical Trial

Recruiting·Paulista University·Preclinical·NCT07342634·80 enrolled

Uality of Recovery-15 After Opioid-free Versus Opioid-based General Anesthesia in Patients Undergoing Elective Major Urological Surgery: A Randomized Controlled Trial

Recruiting·JJagiellonian University·Preclinical·NCT07665463·200 enrolled

Ultrasound-Guided Subtransverse Interligamentary Plane Block Versus Thoracic Paravertebral Block for Quality of Recovery After Modified Radical Mastectomy: A Randomized Non-Inferiority Trial

Recruiting·TTanta University·Preclinical·NCT07647367·60 enrolled

Feasibility of Early Gabapentin as an Intervention for Neurorecovery

Recruiting·MMetroHealth Medical Center·Phase 4·NCT05302999·42 enrolled

Adjunctive Cannabidiol for Recovery From Opioid Study

Recruiting·IIcahn School of Medicine at Mount Sinai·Phase 3·NCT06940674·450 enrolled

Research on Clinical Recovery and Maintenance Strategies for CHB

Recruiting·—·N/A·NCT06803368·285 enrolled

Perioperative Argon Inhalation to Improve Neurocognitive Recovery After Carotid Surgery

Recruiting·NNegovsky Reanimatology Research Institute·Phase 3·NCT07200180·100 enrolled

Effect of Liberal and Restrictive IV Fluids on Recovery After Gallbladder Surgery

Recruiting·KKing Edward Medical University·Phase 1·NCT07488078·380 enrolled

Methadone and Quality of Postoperative Recovery

Recruiting·EEndeavor Health·Phase 4·NCT03168958·130 enrolled

Effect of Erector Spinae (ESP) Block on Opioid Reduction and Enhanced Recovery After Posterior Cervical Spine Surgery

Recruiting·UUniversity Health Network, Toronto·N/A·NCT04646707·52 enrolled

Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

Recruiting·—·Phase 3·NCT03216525·136 enrolled

Improving Postoperative Recovery: A Study of Multimodal Perineal Analgesia Protocol (MPAP) After Vaginal Surgery

Recruiting·UUniversity of Miami·Phase 4·NCT07401134·70 enrolled

Spinal Anesthesia For Enhanced Recovery After Liver Surgery

Recruiting·UUniversity of Manitoba·N/A·NCT03715517·128 enrolled

Effect of Dezocine Combined With Sufentanil on the Quality of Postoperative Recovery and Analgesic Effect in Patients Undergoing Thoracic Surgery

Recruiting·YYangtze River Pharmaceutical Group Co., Ltd.·Phase 4·NCT06439368·210 enrolled

ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty

Recruiting·PProf. Stavros Konstantinides, MD·Phase 3·NCT06611319·2,932 enrolled

Page 1 of 13

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)